RxDoctor Payments Data

Jennifer Avise, MD

Vascular Surgery · Pleasanton, CANPI 1801039615

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (46.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Alphatec Spine, Inc accounts for 70.5% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2024 at $16,701 and has fallen 72.6% since, to $4,568 in 2025.

$34,609in general payments, 2019–2025

Across 167 payments — averaging $207.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alphatec Spine, Inc$24K
  • Medtronic$3K
  • Bard Peripheral Vascular, Inc.$2K
  • Globus Medical$2K
  • Silk Road Medical, Inc.$2K
  • Shockwave Medical, Inc$387
  • plus $717 from 7 others

What the payments were for

  • Consulting fees$16,00046%
  • Travel & lodging$12,84037%
  • Food & beverage$5,73417%
  • Education$350%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,609 in reported general payments places this provider in the 85th percentile of 519 vascular surgery providers in California.

See all vascular surgery providers in California →

Medicare billing

Part B allowed, 2024
$226,054
Medicare patients
272
Services billed
952

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine-PrilocaineLidocaine/Prilocaine11$145
ClopidogrelClopidogrel Bisulfate34$70

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Pleasanton

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →